Our newly developed allogeneic NK cell line (NK101) with the best-in-class scalability ensures large-scale production of NK cells of uniform quality for clinical use.
NK Cell Line
NK101 cell line retains functional characteristics of CD56dimCD62L+ NK cells, possessing the capacity to kill and produce cytokines at the same time.
Allogeneic NK cell line armed with 4th generation CAR composed of
NK cell-specific signaling domains and CAR-inducible cytokine secretion system for adoptive immunotherapy.